How to buy Medigus stock

Medigus Ltd is a medical devices business based in the US. Medigus shares (MDGS) are listed on the NASDAQ and all prices are listed in US Dollars. Medigus employs 20 staff and has a trailing 12-month revenue of around USD$202,000.

How to buy shares in Medigus

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Medigus. Find the stock by name or ticker symbol: MDGS. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Medigus reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Medigus, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Medigus. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced traders

Interactive Brokers

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active traders. We picked Interactive Brokers for this category because it offers advanced tools and low fees for active investors and pros. The simpler IBKR Lite platform is aimed at less-active investors, but all users older than 21 must meet a $20,000 liquid net worth requirement for a cash account.

What's in this guide?

1. MDGS shares summary
2. Compare share dealing platforms
3. Is MDGS stock a buy or sell?
4. Stock performance over time
5. Can I short MDGS shares?
6. Medigus's financials
7. How volatile are MDGS shares?
8. Does Medigus pay a dividend?
9. Have MDGS shares ever split?
10. Other common questions

Medigus share price

Use our graph to track the performance of MDGS stocks over time.

Medigus shares at a glance

• Key figures

Information last updated 2021-02-23.

52-week range	USD$0.83 - USD$5.15
50-day moving average	USD$2.8915
200-day moving average	USD$2.119
Wall St. target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-1.78

Buy Medigus shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Moomoo		$0 for US stocks	Stocks, Options, ETFs	$0		N/A	Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Medigus stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Medigus Ltd by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting Medigus shares

There are currently 85,769 Medigus shares held short by investors – that's known as Medigus's "short interest". This figure is 35.9% up from 63,130 last month.

There are a few different ways that this level of interest in shorting Medigus shares can be evaluated.

Medigus's "short interest ratio" (SIR)

Medigus's "short interest ratio" (SIR) is the quantity of Medigus shares currently shorted divided by the average quantity of Medigus shares traded daily (recently around 4.3 million). Medigus's SIR currently stands at 0.02. In other words for every 100,000 Medigus shares traded daily on the market, roughly 20 shares are currently held short.

However Medigus's short interest can also be evaluated against the total number of Medigus shares, or, against the total number of tradable Medigus shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Medigus's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Medigus shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Medigus shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Medigus.

Find out more about how you can short Medigus stock.

Have Medigus's shares ever split?

Medigus's shares were split on a 1:4 basis on 16 July 2018. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Medigus shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Medigus shares which in turn could have impacted Medigus's share price.

Medigus share price volatility

Over the last 12 months, Medigus's shares have ranged in value from as little as $0.83 up to $5.15. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Medigus's is 2.5032. This would suggest that Medigus's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Medigus overview

Medigus Ltd., a medical device company, develops, produces, and markets minimally invasive endo-surgical tools and direct visualization technology in the United States, Europe, Asia, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. Medigus Ltd. was founded in 1999 and is headquartered in Omer, Israel.

Frequently asked questions

• What percentage of Medigus is owned by insiders or institutions?

  Currently 2.824% of Medigus shares are held by insiders and 10.945% by institutions.

• How many people work for Medigus?

  Latest data suggests 20 work at Medigus.

• When does the fiscal year end for Medigus?

  Medigus's fiscal year ends in December.

• Where is Medigus based?

  Medigus's address is: No. 7A, Omer Industrial Park, Omer, Israel, 8496500

• What is Medigus's ISIN number?

  Medigus's international securities identification number is: US58471G3002

• What is Medigus's CUSIP number?

  Medigus's Committee on Uniform Securities Identification Procedures number is: 58471G102